This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Medical Affiliated Research Center
Huntsville, Alabama, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Quality of Life Medical & Research Center, LLC
Tucson, Arizona, United States
University of California, Department of Family and Preventative Medicine
La Jolla, California, United States
Downtown Women's Health Care
Denver, Colorado, United States
Coastal Connecticut Research
New London, Connecticut, United States
South Florida Medical Research
Aventura, Florida, United States
Clinical Study Center
Fort Myers, Florida, United States
Center For Marital and Sexual Health of South Florida
West Palm Beach, Florida, United States
Northeast Indiana Research
Fort Wayne, Indiana, United States
Center for Sexual Medicine at Sheppard Pratt
Baltimore, Maryland, United States
...and 10 more locations